Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020)

The Effectiveness of Remdesivir versus Ruxolitinib as Covid-19 Supportive Management: Systematic Review, Meta-Analysis

Authors
Nuriyatul Fhatonah, Ma’sum, Zenith Putri Dewianti, Nur’aini, Nita Rusdiana
Corresponding Author
Nuriyatul Fhatonah
Available Online 16 January 2021.
DOI
https://doi.org/10.2991/ahsr.k.210115.114How to use a DOI?
Keywords
Covid-19, Remdesivir, Ruxolitinib, Systemic Review, Meta-Analysis
Abstract

The treatment regimen in severe Covid-19 patients has several types of therapies. However, there is uncertainty about which therapies are more effective in the covid-19 weight category. In June 2020, the study was conducted with keyword search [REMDESIVIR] [RUXOLITINIB] [COVID19] in 2010-2020 using PUBMED.gov. This study used rct (randomization controller trial) method with the theme: the comparison of the effectiveness use of Remdesivir with Ruxolitinib on Covid-19. From the results of the analysis using forest plot obtained, there was a significant difference in the administration of Remdesivir therapy with Ruxolitinib on the improvement from covid-19 on day 7 (1.26 CI 95% 0.41 to 3.86) and day 14 (RR 1.26 CI 95% 0.41 to 3.86). Ruxolitinib therapy is more effective than Remdesivir applied for Covid-19 patients.

Copyright
© 2021, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

Volume Title
Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020)
Series
Advances in Health Sciences Research
Publication Date
16 January 2021
ISBN
978-94-6239-315-8
ISSN
2468-5739
DOI
https://doi.org/10.2991/ahsr.k.210115.114How to use a DOI?
Copyright
© 2021, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - CONF
AU  - Nuriyatul Fhatonah
AU  - Ma’sum
AU  - Zenith Putri Dewianti
AU  - Nur’aini
AU  - Nita Rusdiana
PY  - 2021
DA  - 2021/01/16
TI  - The Effectiveness of Remdesivir versus Ruxolitinib as Covid-19 Supportive Management: Systematic Review, Meta-Analysis
BT  - Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020)
PB  - Atlantis Press
SP  - 604
EP  - 607
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.210115.114
DO  - https://doi.org/10.2991/ahsr.k.210115.114
ID  - Fhatonah2021
ER  -